Challenges to Medical Data Integrity

This chapter explores the systemic issues affecting access to reliable medical data, particularly influenced by pharmaceutical companies and government policies. It highlights recent experiences with pancreatic cancer statistics, emphasizing the need for transparency and accountability in healthcare. The discussion also covers legislative efforts to make certain medications like ivermectin more accessible and the personal experiences surrounding its use.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app